Critical Periods After Stroke Study (CPASS)

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Lyen an sove nan clipboard la

Estati

Patwone

MedStar National Rehabilitation Network

Kolaboratè

Georgetown University

University of Wisconsin, Madison

The Catholic University of America

Medstar Health Research Institute

ESÈ KLINIK: NCT02235974

BioSeek: nct02235974

Mo kle

Abstrè

To perform an exploratory single center randomized study that will form the basis for a larger scale, more definitive randomized clinical trial to determine the optimal time after stroke for intensive motor training. The investigators will perform a prospective exploratory study of upper extremity (UE) motor training delivered at higher than usual intensity at three different time points after stroke:

- early (initiated within 30 days)

- subacute/outpatient (initiated within 2-3 months)

- chronic (initiated within 6-9 months)

The control group will not receive the therapy intervention during the 1-year study.

Outcome measures will be assessed at baseline, pre-treatment, post-treatment, 6 months and one year after stroke onset.

Compared to individuals randomized during the outpatient (2-3 months after stroke onset) or chronic (6-9 months after stroke onset) time points, participants randomized to early intensive motor training will show greater upper extremity motor improvement measured at one year post stroke.

Deskripsyon

Please see the following reference:

Dromerick, A.W., Edwardson, M., Edwards, D.F., Giannetti, M.L., Barth, J., Brady, K.P., Chan, E., Tan, M.T., Tamboli, I., Chia, R., Orquiza, M., Padilla, R.M., Cheema, A.K., Mapstone, M., Fiandaca, M.S., Federoff, H.J., & Newport, E.L. (2015). Critical Periods after Stroke Study: Translating animal stroke recovery experiments into a clinical trial. Frontiers in Human Neuroscience, 9, 002231. PMCID: PMC4413691.

Dat

Dènye verifye:	03/31/2020
Premye Soumèt:	07/13/2014
Enskripsyon Estimasyon Soumèt:	09/04/2014
Premye afiche:	09/09/2014
Dènye Mizajou Soumèt:	04/05/2020
Dènye Mizajou afiche:	04/06/2020
Dat aktyèl kòmanse etid la:	08/25/2014
Dat Estimasyon Prensipal Estimasyon an:	12/30/2020
Dat estime fini etid la:	01/30/2021

Kondisyon oswa maladi

Stroke

Brain Infarction

Brain Ischemia

Cerebral Infarction

Cerebrovascular Disorders

Entèvansyon / tretman

Behavioral: Acute/Early

Behavioral: Sub-acute/Outpatient

Behavioral: Chronic

Behavioral: Control

Faz

Gwoup bra

Bra	Entèvansyon / tretman
Experimental: Acute/Early Intervention: A 20-hour dose of early intensive upper extremity motor training therapy will be initiated within 30 days post-stroke.	Behavioral: Acute/Early Using a shaping therapy protocol, participants will receive a dose of 20 hours of intensive upper extremity therapy (in addition to their current therapy) beginning within 30 days of stroke onset.
Experimental: Sub-acute/Outpatient Intervention: A 20-hour dose of sub-acute intensive upper extremity motor training therapy will be initiated within 2 to 3 months post-stroke.	Behavioral: Sub-acute/Outpatient Using a shaping therapy protocol, participants will receive a dose of 20 hours of intensive upper extremity therapy (in addition to their current therapy) beginning within 2 to 3 months post stroke.
Experimental: Chronic Intervention: A 20-hour dose of chronic intensive upper extremity motor training therapy will be initiated 6 to 9 months post-stroke	Behavioral: Chronic Using a shaping therapy protocol, participants will receive a dose of 20 hours of intensive upper extremity therapy (in addition to their current therapy) beginning within 6 to 9 months post stroke.
Placebo Comparator: Control Intervention: Usual and customary care. No additional therapy will be initiated during the 1-year study.	Behavioral: Control Usual and Customary Care only. No additional therapy will be given during the 1-year study.

Kritè kalifikasyon yo

Laj ki kalifye pou etid	21 Years Pou 21 Years
Sèks ki kalifye pou etid	All
Aksepte Volontè Healthy	Wi
Kritè	Inclusion Criteria: - Ischemic or hemorrhagic stroke (with confirmatory neuroimaging) within 28 days of admission to inpatient rehabilitation (allows those randomized to the early arm to begin study-related treatment within 30 days) - Age >21 years - Able to participate in first study-related treatment session within 30 days of stroke onset - Able to participate in all study-related activities, including one year follow up and blood draws - Persistent hemiparesis leading to impaired upper extremity function. Hemiparesis as indicated by NIHSS Motor Arm score ≥ 1 - Recovering moderate motor impairment at the shoulder and elbow or hand such as: - Proximal UE voluntary activity indicated by a score of ≥ 3 on the upper arm item of the Motor Assessment Scale - wrist and finger movement is not required or - Manual Muscle Test (MMT) score of ≥ 2 on shoulder flexion or abduction and MMT score of ≥ 2 for any of the following: elbow flexion, elbow extension, wrist flexion, wrist extension, finger flexion or finger extension. or - Active range of motion (AROM) to at least 50% of range in gravity eliminated position for shoulder flexion or abduction, and for any of the following motions: elbow flexion, elbow extension, wrist flexion, wrist extension, finger flexion or finger extension. - Score of ≤ 8 on the Short Blessed Memory Orientation and Concentration Scale - Follows 2 step commands - No upper extremity injury or conditions that limited use prior to the stroke - Pre-stroke independence: Modified Rankin Score 0 or 1 Exclusion Criteria: - Inability to give informed consent - Prior stroke with persistent motor impairment or other disabling neurologic condition such as multiple sclerosis, parkinsonism, amyotrophic lateral sclerosis (ALS), dementia requiring medication - Rapidly improving motor function - Clinically significant fluctuations in mental status in the 72 hours prior to randomization - Hemispatial neglect as determined by >3 errors on the Mesulam Symbol Cancellation Test - Not independent prior to stroke (determined by scores of <95 on Barthel Index or >1 on Modified Rankin Scale - Dense sensory loss indicated by a score of 2 on NIHSS sensory item - Ataxia out of proportion to weakness in the affected arm as described by a score of ≥ 1 on the NIHSS limb ataxia item - Active or prior psychosis within 2 years - Active or prior (within 2 years) substance abuse - Not expected to survive 1 year due to other illnesses (cardiac disease, malignancy, etc) - Received upper extremity botulinum toxin within 6 months (other medications do not exclude)

Rezilta

Mezi Rezilta Prensipal yo

1. Action Research Arm Test (ARAT) [Baseline (within 30 days post stroke), pre-treatment, post-treatment (ideally within 72 hours after treatment has ended), 6 months and 1 year post stroke]

The ARAT assesses functional limitations and evaluates changes in limb function for the upper extremity.

Mezi Rezilta Segondè

1. Motor Activity Log - 28 Quality of Movement (MAL-28 QOM) [Pre-treatment, post-treatment (ideally within 72 hours after treatment has ended), 6 months and 1 year post stroke]

A structured interview to measure upper extremity use and function as well as assess the quality of movement of the hemiparetic arm.

2. Nine Hole Peg Test (9-HPT) [Baseline (within 30 days post stroke), pre-treatment, post-treatment (ideally within 72 hours after treatment has ended), 6 months and 1 year post stroke]

A standardized quantitative test of upper extremity function and fine manual dexterity.

3. Functional Independence Measure (FIM) [Baseline (within 30 days post stroke), pre-treatment, post-treatment (ideally within 72 hours after treatment has ended), 6 months and 1 year post stroke]

A basic indicator of severity of disability. Tracks changes in the functional ability of the patient during an episode of hospital rehabilitation care.

4. Barthel Index (BI) [Baseline (within 30 days post stroke), pre-treatment, post-treatment (ideally within 72 hours after treatment has ended), 6 months and 1 year post stroke]

Measures performance in activities of daily living and functional disability.

5. Motricity Index - Arm only (MI) [Baseline (within 30 days post stroke), pre-treatment, post-treatment (ideally within 72 hours after treatment has ended), 6 months and 1 year post stroke]

To assess motor impairment and strength in the upper extremity.

6. Perception of change (POC) [Baseline (within 30 days post stroke), pre-treatment, post-treatment (ideally within 72 hours after treatment has ended) and 1 year post stroke]

A stroke-specific self-report to assess how stroke has impacted a person's life and their overall perception of recovery.

7. Stroke Impact Scale - Hand-Arm subscale (SIS) [Baseline (within 30 days post stroke), pre-treatment, post-treatment (ideally within 72 hours after treatment has ended) and 1 year post stroke]

A self-report health status measure to assess perceived recovery with regard to the more affected hand and arm following a stroke.

8. Modified Rankin Scale (MRS) [Baseline (pre-stroke assessment), pre-treatment, post-treatment (ideally within 72 hours after treatment has ended) and 1 year post stroke]

A measure of the degree of disability or dependence in daily activities following a stroke.

9. Activity Card Sort (ACS) [Pre-treatment (ideally within 72 hours of baseline), post-treatment (ideally within 72 hours after treatment has ended), 6 months and 1 year post stroke]

An interview-based assessment used to measure an individual's participation in instrumental, leisure and social activities.

10. Reintegration to Normal Living Index (RNLI) [Post-treatment (within 72 hours after treatment has ended), 6 months and 1 year post stroke]

To assess quantitatively the degree that individuals who have experienced a traumatic injury or illness come to manage and reintegrate normal social activities with regard to recreation, movement at home and within the community, family and relationships.

11. Geriatric Depression Scale (GDS-15) [Baseline (within 30 days post stroke), pre-treatment, and 1 year post stroke]

A self-report assessment used to identify depressive symptoms in the elderly.

12. NIH Stroke Scale (NIHSS) [Baseline (within 30 days post stroke), pre-treatment, 6 months and 1 year post stroke]

A systematic assessment used to evaluate and measure stroke-related. neurological impairments and stroke severity.

13. Short Blessed Orientation and Memory Concentration Test (SBT) [Baseline (within 30 days post stroke)]

An assessment of cognitive ability and impairment.

14. Mesulam Symbol Cancellation Test (SCT) [Baseline (within 30 days post stroke)]

An assessment used to evaluate visuospatial function and attention.

15. Faces Pain Scale [Baseline (within 30 days post stroke), pre-treatment, post-treatment (ideally within 72 hours after treatment has ended), 6 months and 1 year post stroke]

A self-report measure of pain intensity.

16. Fugl Meyer Assessment (Upper Extremity) [Baseline (within 30 days post stroke) and 1 year post stroke]

A performanced-based impairment index to assess motor function, sensation and joint function.

17. Manual Muscle Test (Upper Extremity) [Baseline (within 30 days post stroke)]

Muscle strength assessment

Lòt Mezi Rezilta

1. Motor Assessment Scale - Upper Arm Function (MAS) [Baseline (within 30 days of stroke onset)]

Performance-based scale to assess everyday motor function.

Critical Periods After Stroke Study (CPASS)

Mo kle

stroke

salvia

salvia hispanica

salvia columbariae